netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
News
News Title
news

14/10/19: Update on current supply issue of all brands of adrenaline auto-injectors

Clinicians should note the latest stock availability update from DHSC concerning adrenaline auto-injectors (see table below). Due to the supply issues with some brands, it may be necessary to switch patients to an alternative brand that they are unfamiliar with. Clinicians should support switching and ensure patients know how to use the alternative product that is supplied. 

Adrenaline auto-injector brand
Strength
MA Holder
Stock Availability
EpiPen Junior
150 micrograms
Mylan UK
Available under prescription validation
EpiPen
300 micrograms
Mylan UK
Available under prescription validation
Jext
150 micrograms
ALK-Abello
Available
Jext
300 micrograms
ALK-Abello
Available from w/c 14th October
Emerade
150 micrograms
Bausch & Lomb
Available
Emerade
300 micrograms
Bausch & Lomb
Available from w/c 14th October
Emerade
500 micrograms
Bausch & Lomb
Available from 18th October

Specific training and advice are required for each of the devices. Please follow the links to the relevant training videos below:

EpiPen:            http://www.epipen.co.uk/demonstrationvideo/

Jext:                 https://hcp.jext.co.uk/

Emerade:          https://www.emerade-bausch.co.uk/patient/how-to-use-emerade

    
14/10/2019
   
news

01/08/2019:  Emerade® adrenaline auto-injectors supply issues

There is a short-term supply issue affecting Emerade® 500 microgram and 300 microgram adrenaline auto-injectors (AAIs). Bausch & Lomb are the sole UK supplier of Emerade® devices in the UK. New supplies of Emerade® 500 microgram are expected by the end of August 2019. Limited stock of Emerade® 300 microgram is available. Currently, new supplies are expected by the end of September 2019.

Two alternative AAI devices are available in the UK- EpiPen® and Jext®. Both Jext® and EpiPen® AAIs are currently available, however, supplies of Jext® are unlikely to be sufficient to support a significant switch to this product and therefore where there is no patient / clinician preference, EpiPen® should be considered as the first line alternative. The devices differ slightly in the administration technique and specific training is required for each device.

    
01/08/2019
   
news

16/07/19: Diamorphine 5mg injection supply issue

There is currently supply issues with Diamorphine 5mg injections. The national Medicines Shortage Response Group (MSRG) have recommended the following:

Primary care, private hospitals, hospices & substance misuse treatment centres:There is sufficient diamorphine 10mg injection to support the forecasted use of the diamorphine 5mg strength. Order stock from usual wholesalers.

Secondary care NHS Trusts: Hameln's morphine 10mg injection (p/free) is the first line alternative. Trusts should order in line with historical demand. Do not stockpile which may potentiate supply issues of this product.

    
16/07/2019
   
news

31.05.2019: HRT Supply Issues

There are currently stock availability issues for a number of Hormonal Replacement Therapy preperations, please establish local availability prior to issuing prescriptions. For further information and guidance please contact the Medicines Optimisation Queries Team at southstaffs.medsoptimisation@nhs.net

 

    
05/06/2019
   
news

16/05/19: Epanutin 50mg Infatabs Supply Issue

Clinicians should read the attached information from the Department of Health and Social Care (DHSC) concerning global supply issues of Epanutin 50mg Infatabs until November 2019. Prescribers must exercise caution and increase patient monitoring if prescribing a product from a different manufacturer as this is a Category 1 antiepileptic drug.

    
16/05/2019
   
news

11/03/2019 - Changes to the Amber drug classification on the South Staffordshire Joint Formulary as approved by Stafford & Surrounds Membership board and APG. These changes are effective from today 11th March 2019.

Amber- Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care. This replaces Amber 1 on the South Staffs Formulary.

Amb E- Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require an ESCA (Shared Care Agreement). This replaces Amber 2 on the South Staffs Formulary.

For further queries and support, please contact your Practice support pharmacist or email: southstaffs.medsoptimisation@nhs.net . Thank you.

    
11/03/2019
   
news

06/11/2018 - EPS - Frequently asked questions, General Practice Guidance has been added to the Communications and Drug discontinuation tile

    
06/11/2018
   
news

27/09/2018 - Antibiotic Campaign 2018. The Staffordshire and Stoke-on Trent CCGs are launching their antibiotic campaign for 2018 - Save our Antibiotics – be self-care aware.  Resources will be sent out to GP practices during October.

    
17/10/2018
   
news

26/09/2018 - Adrenaline / Epinephrine (Soln for injection) Auto-Injector - Please prescribe generically due to variable stock shortages of each of the three brands - Jext, Emerade and Epipen.

    
26/09/2018
   
news

15/08/18 Information on the Over-the-Counter policy can be found here:  over the counter policies

    
15/08/2018
   
news

26/07/2018 - Inhaler technique videos have been added to the formulary Inhaler technique videos a direct link is also available from the beginning of the respiratory chapter

    
26/07/2018
   
news

07/06.18 New updated version of decline to prescribe form

Decline to prescribe form v2

    
07/06/2018
   
news

21/05/2018 New Diabetes guidelines published Diabetes Guidelines

    
23/05/2018
   
news

16/05/18 New contraceptives guideline published  Contraceptives guideline

    
16/05/2018
   
news

South Staffordshire list of preferred medication brands is published South staffordshire preferred brands

    
16/05/2018
   
news

03/05/2018 - NEW DM+D mapping guidance for GP Clinical Systems Emis Web and System One have been added to the Communications and Drug discontinuation tile

    
03/05/2018
   
news 7/11/17 At present we do not support the prescribing on the NHS of Freestyle Libre full review is undertaken by the Clinical Priority Advisory Group. We are aware of all recent literature and are using this as part of the review process. Freestyle Libre interim statement    
07/11/2017
   
news 1/11/17 updated version of Denosumab RICad    
01/11/2017
   
news 05/09/17 New asthma and COPD guidelines Respiratory guidelines    
05/09/2017
   
news 05/06/17 A patient information leaflet has been produced to give sick day rules for medications in order to avoid dehydration Link to medicines and dehydration patient leaflet    
05/06/2017
   
news 05/06/17 Biosimilar Insulin glargine Abasaglar® added to formulary Biosimilar Insulin statement    
05/06/2017
   
news 04/04/17 All new updated CCG PGDS now available CCG PGDS    
04/04/2017
   
news 21/03/17 Three new ESCAS Penicllamine, Sodium authoriomalate and Sulfasalazine    
04/04/2017
   
news 26/1/17 Three new ESCAS now available for Burton Hospitals Methotrexate, Leflunomide, Azathioprine and a RICad for Sacubitril valsartan (Entresto)     
30/01/2017
   
news 20/01/17 NEW Both adult and childrens gluten free guidelines have been updated nutrition and blood guidelines    
20/01/2017
   
news 16/01/17 NEW Continence formulary uploaded to formularies and guidelines section    
16/01/2017
   

 

 

 

 


netFormulary